Insider trades
Ilya Goldshleger, COO of RxSight RXST, has filed 0 purchases and 59 sales on the open market. The latest trade was on 04/17.
Ilya Goldshleger
COO
- Company
- RxSight RXST
- First filing
- 23/03/10
- Trades
- 153 trades
- Buys / sales
- 0 / 59
- 12-month net buying
- No record
- Last trade
- 04/17
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
RxSightRXST | Open-market sale10b5-1 plan | 24/11/29 | 24/12/03 | 3,105 sh | $46.08 | $143,078.4 | −6.8% |
| Open-market sale10b5-1 plan | 24/11/22–24/11/26 | 24/11/26 | 6,200 sh2 trades | $45.44avg. | $281,728 | −12.8% | |
| Open-market sale10b5-1 plan | 24/11/15–24/11/18 | 24/11/18 | 7,975 sh3 trades | $45.61avg. | $363,752.31 | −15.9% | |
RxSightRXST | Open-market sale10b5-1 plan | 24/11/12 | 24/11/14 | 1,330 sh | $46.13 | $61,352.9 | −3.1% |
| Open-market sale10b5-1 plan | 24/11/07 | 24/11/08 | 3,100 sh2 trades | $55.00avg. | $170,490 | −6.8% | |
| Open-market sale10b5-1 plan | 24/11/04 | 24/11/05 | 3,100 sh2 trades | $51.04avg. | $158,235.6 | −6.8% | |
RxSightRXST | Open-market sale10b5-1 plan | 24/10/30 | 24/10/31 | 3,105 sh | $51.91 | $161,180.55 | −6.8% |
| Open-market sale10b5-1 plan | 24/10/25–24/10/28 | 24/10/28 | 6,200 sh2 trades | $50.22avg. | $311,333 | −12.8% | |
RxSightRXST | Open-market sale10b5-1 plan | 24/10/22 | 24/10/22 | 3,100 sh | $49.68 | $154,008 | −6.8% |
| Open-market sale10b5-1 plan | 24/10/16–24/10/18 | 24/10/18 | 6,205 sh4 trades | $49.93avg. | $309,837.53 | −12.8% | |
| Open-market sale10b5-1 plan | 24/10/10–24/10/14 | 24/10/15 | 9,305 sh3 trades | $49.70avg. | $462,454.1 | −18.1% | |
| Open-market sale10b5-1 plan | 24/10/04–24/10/08 | 24/10/08 | 6,200 sh4 trades | $48.14avg. | $298,438.42 | −12.8% | |
| Open-market sale10b5-1 plan | 24/09/26–24/09/30 | 24/09/30 | 6,205 sh3 trades | $49.15avg. | $304,983.57 | −12.8% | |
| Open-market sale10b5-1 plan | 24/09/20–24/09/23 | 24/09/23 | 6,200 sh3 trades | $52.93avg. | $328,147.5 | −12.8% | |
RxSightRXST | Open-market sale10b5-1 plan | 24/09/17 | 24/09/18 | 3,100 sh | $56.11 | $173,941 | −6.8% |
| Open-market sale10b5-1 plan | 24/08/05 | 24/08/06 | 9,000 sh6 trades | $39.25avg. | $353,288.86 | −17.6% | |
| Open-market sale10b5-1 plan | 24/02/14–24/02/16 | 24/02/16 | 25,000 sh5 trades | $54.00avg. | $1,350,000 | −48.6% | |
| Open-market sale10b5-1 plan | 24/02/09 | 24/02/12 | 10,365 sh2 trades | $50.74avg. | $525,932.5 | −28.1% | |
| Open-market sale10b5-1 plan | 24/02/01 | 24/02/02 | 7,129 sh3 trades | $49.29avg. | $351,411 | −21.2% | |
RxSightRXST | Open-market sale10b5-1 plan | 24/01/22 | 24/01/22 | 5,000 sh | $48.00 | $240,000 | −15.9% |